Supernus Pharmaceuticals Cash from Financing (TTM) Analysis

Supernus Pharmaceuticals Inc (SUPN)

28.94 -1.04 (-3.48%) USD | NASDAQ | May 10, 16:00

28.94 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2011. Upgrade now.

Date	Value
December 31, 2023	-397.88M
September 30, 2023	-396.14M
June 30, 2023	-389.46M
March 31, 2023	91.73M
December 31, 2022	-10.48M
September 30, 2022	-150.05M
June 30, 2022	-155.18M
March 31, 2022	-154.70M
December 31, 2021	-130.42M
September 30, 2021	9.389M
June 30, 2021	7.086M
March 31, 2021	5.774M
December 31, 2020	3.559M
September 30, 2020	1.753M
June 30, 2020	2.974M
March 31, 2020	3.177M
December 31, 2019	3.928M
September 30, 2019	3.916M
June 30, 2019	4.502M
March 31, 2019	9.508M
December 31, 2018	376.44M
September 30, 2018	376.36M
June 30, 2018	377.88M
March 31, 2018	372.79M
December 31, 2017	5.681M

Date	Value
September 30, 2017	5.307M
June 30, 2017	3.221M
March 31, 2017	2.532M
December 31, 2016	2.052M
September 30, 2016	2.055M
June 30, 2016	1.853M
March 31, 2016	1.844M
December 31, 2015	1.867M
September 30, 2015	1.373M
June 30, 2015	31.33M
March 31, 2015	30.71M
December 31, 2014	30.57M
September 30, 2014	28.81M
June 30, 2014	-1.222M
March 31, 2014	63.76M
December 31, 2013	62.74M
September 30, 2013	106.57M
June 30, 2013	104.36M
March 31, 2013	87.95M
December 31, 2012	87.92M
September 30, 2012	60.43M
June 30, 2012	61.34M
March 31, 2012	13.42M
December 31, 2011	27.09M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-397.88M

Minimum

Dec 2023

91.73M

Maximum

Mar 2023

-86.66M

Average

2.974M

Median

Jun 2020

Cash from Financing (TTM) Benchmarks